Stock Events

Stock Events

Medicure 

€0.74
0
-€0-0% Friday 14:17

Statistics

Day High
0.74
Day Low
0.74
52W High
0.79
52W Low
0.35
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22AprExpected
Q2 2021
Next
-0.04
0.29
0.63
0.96
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NGQ1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap187.56B
Amgen develops and produces medications in similar therapeutic areas as Medicure, including cardiovascular drugs.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that manufactures drugs like Entresto, competing in the cardiovascular market.
Pfizer
PFE
Mkt Cap161.09B
Pfizer produces a range of cardiovascular treatments, directly competing with Medicure's heart health products.
Merck
MRK
Mkt Cap298.84B
Merck & Co. offers cardiovascular therapies, including Zetia and Vytorin, which compete in the same space as Medicure.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol-Myers Squibb produces cardiovascular drugs, competing directly with Medicure's product offerings.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie, through its acquisition of Allergan, has expanded into cardiovascular treatments, competing with Medicure.
Astrazeneca
AZN
Mkt Cap315.47B
AstraZeneca has a strong portfolio in cardiovascular diseases, including drugs like Brilinta, competing with Medicure.
Lilly(Eli) &
LLY
Mkt Cap837.36B
Eli Lilly and Company competes in the cardiovascular market, which overlaps with Medicure's therapeutic focus.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline produces medications for heart diseases, competing in the same therapeutic areas as Medicure.
Sanofi
SNY
Mkt Cap116.63B
Sanofi offers a range of cardiovascular treatments, directly competing with Medicure in this therapeutic area.

About

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Show more...
CEO
Dr. Albert David Friesen Ph.D.
Employees
23
Country
US
ISIN
CA58469E4085

Listings

STU
DE
NGQ1.STU
V
CA
MPH.V
F
DE
NGQ1.F
OTC Link
US
MCUJF

0 Comments

Share your thoughts

FAQ

What is Medicure stock price today?▼
The current price of NGQ1.STU is €0.74 EUR — it has decreased by -0% in the past 24 hours. Watch Medicure stock price performance more closely on the chart.
What is Medicure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Medicure stocks are traded under the ticker NGQ1.STU.
Is Medicure stock price growing?▼
NGQ1.STU stock has fallen by -0% compared to the previous week, the month change is a +26.5% rise, over the last year Medicure has showed a +59.48% increase.
When is the next Medicure earnings date?▼
Medicure is going to release the next earnings report on April 22, 2026.
What were Medicure earnings last quarter?▼
NGQ1.STU earnings for the last quarter are -0.04 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Medicure have?▼
As of April 11, 2026, the company has 23 employees.
In which sector is Medicure located?▼
Medicure operates in the Health Care sector.
When did Medicure complete a stock split?▼
Medicure has not had any recent stock splits.
Where is Medicure headquartered?▼
Medicure is headquartered in Winnipeg, US.